0001514346-11-000007.txt : 20110317 0001514346-11-000007.hdr.sgml : 20110317 20110317204244 ACCESSION NUMBER: 0001514346-11-000007 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110315 FILED AS OF DATE: 20110317 DATE AS OF CHANGE: 20110317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bielasz Jennifer Kathleen CENTRAL INDEX KEY: 0001514346 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31161 FILM NUMBER: 11696556 MAIL ADDRESS: STREET 1: C/O ARENA PHARMACEUTICALS, INC. CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584537200 MAIL ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 edgar.xml PRIMARY DOCUMENT X0203 3 2011-03-15 0 0001080709 ARENA PHARMACEUTICALS INC ARNA 0001514346 Bielasz Jennifer Kathleen C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 Sr. Dir. of Accounting & Cont. Common Stock 7666 D Employee Stock Option (right to buy) 12.25 2012-01-15 Common Stock 2500 D Employee Stock Option (right to buy) 11.31 2012-07-19 Common Stock 5000 D Employee Stock Option (right to buy) 6.00 2014-01-18 Common Stock 5000 D Employee Stock Option (right to buy) 4.41 2014-10-08 Common Stock 2500 D Employee Stock Option (right to buy) 6.16 2015-01-17 Common Stock 4500 D Employee Stock Option (right to buy) 16.80 2016-01-20 Common Stock 3000 D Employee Stock Option (right to buy) 10.52 2016-07-28 Common Stock 4000 D Employee Stock Option (right to buy) 13.50 2017-02-26 Common Stock 6500 D Employee Stock Option (right to buy) 6.99 2018-03-03 Common Stock 6000 D Employee Stock Option (right to buy) 4.01 2019-03-17 Common Stock 6000 D Employee Stock Option (right to buy) 3.25 2020-03-17 Common Stock 9000 D The options vested in four equal annual installments beginning on January 15, 2003. The options vested in four equal annual installments beginning on July 19, 2003. The options vested in four equal annual installments beginning on June 1, 2004. The options vested in four equal annual installments beginning on October 8, 2005. The options were originally for 6,000 shares of common stock, and they vested in four equal annual installments beginning on June 1, 2005. The holder exercised options to purchase 1,500 shares of common stock. The options vested in four equal annual installments beginning on January 20, 2007. The options vested in four equal annual installments beginning on July 28, 2007 The options vested in four equal annual installments beginning on February 26, 2008. The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 3, 2009, the second installment became exercisable on March 3, 2010, the third installment became exercisable on March 3, 2011, and the fourth installment vests on March 3, 2012. The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 17, 2010, the second installment vests on March 17, 2011, the third installment vests on March 17, 2012, and the fourth installment vests on March 17, 2013. The options vest in four equal annual installments beginning on March 17, 2011, and are exercisable once vested. Adam S. Chinnock, as Attorney-in-Fact 2011-03-17 EX-24 2 bielaszsec.htm

POWER OF ATTORNEY



      The undersigned hereby constitutes and appoints each of Jack Lief or his successor as Chief Executive Officer, Steven W. Spector or his successor as General Counsel, Adam S. Chinnock or his successor as Assistant General

Counsel, Corporate and Securities, and Carolyn M. Felzer or her successor as Senior Director of Finance and Administration, and each of them acting singly, as the true and lawful attorney-in-fact of the undersigned to:



(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an employee, officer and/or director (or pending employee, officer and/or director) of Arena Pharmaceuticals, Inc. (the "Company"), Form IDs and Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;



(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and



(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this power of attorney (this "Power of Attorney") shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.



 The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company, attention the foregoing attorneys-in-fact.



This Power of Attorney supersedes any previous power of attorney granted by the undersigned, in the undersigned's capacity as an employee, officer and/or director of the Company, and relating to Form ID, 3, 4, or 5.



      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of March 2011.



   /s/ Jennifer Bielasz

  Jennifer K. Bielasz